Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences
Patients and medical professionals may call 1-800-533-UPMC (8762) for more information.

New Genetic Risk Factor For Susceptibility To Alzheimer’s Disease Identified By University Of Pittsburgh Researchers

PITTSBURGH, June 18, 2001 — Alzheimer’s disease (AD) researchers at the University of Pittsburgh have singled out a new genetic risk factor for the debilitating brain disease that affects 4 million Americans today and will strike as many as 14 million during the next 50 years.

In a decade-long research study following more than 300 first-degree relatives of 189 Alzheimer’s patients, the Pitt researchers identified a small area of chromosome 10 that, when combined with the previously identified APOE E4 gene, significantly increases a person’s risk of developing the disease.

This combination of genes produced a 16-fold increase in the risk of AD among first-degree relatives, said the researchers. By comparison, this effect is greater than the increased risk of lung cancer caused by smoking. These new results are supported by independent studies of AD patients and controls from Pittsburgh, Boston, and Bonn, Germany.

The study results were published today in the July issue of Molecular Psychiatry (pg. 413-419).

"Our findings may provide new opportunities for designing and evaluating treatments that prevent or delay the onset of AD," said George S. Zubenko, M.D., Ph.D., professor of Western Psychiatric Institute and Clinic at the University of Pittsburgh School of Medicine and adjunct professor of biological sciences at Carnegie Mellon University.

Dr. Zubenko and his colleagues studied normal individuals between the ages of 40 and 75 who were first-degree relatives of patients with AD. The subjects were given standard memory evaluation tests to be certain they had not suffered any cognitive decline prior to the start of the study, and then blood samples were drawn to identify genetic and biochemical risk factors for AD and related disorders. Eighteen people developed AD after 11.5 years of regular follow-up evaluations. Ongoing assessments of the remainder of the group and the continuing search for new risk factors is being supported by research grants from the National Institutes of Health, for which Dr. Zubenko serves as the principal investigator.

According to Dr. Zubenko, these findings may provide new molecular targets for therapeutic drug development and will help researchers design trials involving subjects who have the greatest likelihood of responding to therapy and for whom successful therapy would have the greatest impact. Furthermore, the newly discovered risk locus affects brain levels of dopamine, the neurotransmitter used by neurons that degenerate in Parkinson's disease. As a result, the new findings may have relevance for both of these common neurodegenerative disorders.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com